People

Joana Pinto

senior researcher

Research Group
Toxicology
Position
Assistant Researcher (Permanent contract) (since 2025)
Personal Website
View here
Email
jipinto@ff.up.pt
Phone number
+351 220 428 000 (ext: 8796)
ORCID
0000-0001-9719-8364
Ciência Vitae
CC1B-B7A7-4C73

Recent publications

  • Carapito, A; Roque, ACA; Carvalho, F; Pinto, J; de Pinho, PG. 2024. Exploiting volatile fingerprints for bladder cancer diagnosis: A scoping review of metabolomics and sensor-based approaches. TALANTA, 268, DOI: 10.1016/j.talanta.2023.125296
  • de Sousa, TV; de Pinho, PG; Pinto, J. 2023. Metabolomic Signatures of Treatment Response in Bladder Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24, DOI: 10.3390/ijms242417543
  • Amaro, F; Carvalho, M; Bastos, MD; de Pinho, PG; Pinto, J. 2023. Metabolic signature biomarkers for predicting the recurrence of urological cancers. CLINICA CHIMICA ACTA, 549, DOI: 10.1016/j.cca.2023.117553
  • Amaro, F; Pisoeiro, C; Valente, MJ; Bastos, MD; de Pinho, PG; Carvalho, M; Pinto, J. 2022. Sunitinib versus Pazopanib Dilemma in Renal Cell Carcinoma: New Insights into the In Vitro Metabolic Impact, Efficacy, and Safety. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23, DOI: 10.3390/ijms23179898
  • Lima, AR; Carvalho, M; Aveiro, SS; Melo, T; Domingues, MR; Macedo-Silva, C; Coimbra, N; Jeronimo, C; Henrique, R; Bastos, MD; de Pinho, PG; Pinto, J. 2022. Comprehensive Metabolomics and Lipidomics Profiling of Prostate Cancer Tissue Reveals Metabolic Dysregulations Associated with Disease Development. JOURNAL OF PROTEOME RESEARCH, 21, DOI: 10.1021/acs.jproteome.1c00754
  • Amaro, F; Carvalho, M; Bastos, MD; de Pinho, PG; Pinto, J. 2022. Pharmacometabolomics Applied to Personalized Medicine in Urological Cancers. PHARMACEUTICALS, 15, DOI: 10.3390/ph15030295
  • Pinto, J; Amaro, F; Lima, AR; Carvalho-Maia, C; Jeronimo, C; Henrique, R; Bastos, MD; Carvalho, M; de Pinho, PG. 2021. Urinary Volatilomics Unveils a Candidate Biomarker Panel for Noninvasive Detection of Clear Cell Renal Cell Carcinoma. JOURNAL OF PROTEOME RESEARCH, 20, DOI: 10.1021/acs.jproteome.0c00936
  • Pinto, J; Carapito, A; Amaro, F; Lima, AR; Carvalho-Maia, C; Martins, MC; Jeronimo, C; Henrique, R; Bastos, MD; de Pinho, PG. 2021. Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics. Metabolites, 11, DOI: 10.3390/metabo11040199
  • Ana Rita Lima; Joana Pinto; Carina Carvalho-Maia; Carmen Jerónimo; Rui Henrique; Maria de Lourdes Bastos; Márcia Carvalho; Paula Guedes de Pinho. 2020. A Panel of Urinary Volatile Biomarkers for Differential Diagnosis of Prostate Cancer from Other Urological Cancers. Cancers, 12(8), DOI: 10.3390/cancers12082017
  • Lima, AR; Pinto, J; Azevedo, AI; Barros-Silva, D; Jeronimo, C; Henrique, R; Bastos, MD; de Pinho, PG; Carvalho, M. 2019. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine. BRITISH JOURNAL OF CANCER, 121, DOI: 10.1038/s41416-019-0585-4